Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs00037915
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
| Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
|---|---|---|---|---|---|
| Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
NBD | N6-BENZYL-NICOTINAMIDE-ADENINE- DINUCLEOTIDE | A,B,C,D | 1GYQ | 0.72 |  |
DND | NICOTINIC ACID ADENINE DINUCLEOTIDE | A,B,C,D,E,F | 1KQO | 0.73 | |
| DND | NICOTINIC ACID ADENINE DINUCLEOTIDE | A,B | 2H29 | 0.73 | |
| DND | NICOTINIC ACID ADENINE DINUCLEOTIDE | A,B | 1NUQ | 0.73 | |
| DND | NICOTINIC ACID ADENINE DINUCLEOTIDE | A | 1WXG | 0.73 | |
| DND | NICOTINIC ACID ADENINE DINUCLEOTIDE | A,B,C,D,E,F | 1KAQ | 0.73 | |
| DND | NICOTINIC ACID ADENINE DINUCLEOTIDE | A,B | 1EE1 | 0.73 | |
| DND | NICOTINIC ACID ADENINE DINUCLEOTIDE | A,B,C,D | 3E27 | 0.73 | |
| DND | NICOTINIC ACID ADENINE DINUCLEOTIDE | A | 1XQD | 0.73 | |
| DND | NICOTINIC ACID ADENINE DINUCLEOTIDE | A,B | 2H2A | 0.73 | |
| DND | NICOTINIC ACID ADENINE DINUCLEOTIDE | A,B | 1IFX | 0.73 | |
| DND | NICOTINIC ACID ADENINE DINUCLEOTIDE | A,B | 1XNG | 0.73 | |
MR9 | 4-METHYL-3-({3-[2-(METHYLAMINO)PYRIMIDIN- 4-YL]PYRIDIN-2-YL}OXY)-N-[2-MORPHOLIN- 4-YL-5-(TRIFLUOROMETHYL)PHENYL]BENZAMIDE | A,B | 2P4I | 0.73 | |
NHO | NICOTINAMIDE-ADENINE-DINUCLEOTIDE- 5-HYDROXY-4-OXONORVALINE | A,B | 1Q7G | 0.72 | |
ONA | A,C | 2GVZ | 0.8 | | |
PRC | N-[4-METHYL-3-[[4-(3-PYRIDINYL)- 2-PYRIMIDINYL]AMINO]PHENYL]-3-PYRIDINECARBOXAMIDE | A,B | 1FPU | 0.7 | |
AGN | A | 1GNP | 0.77 | | |
4RB | 4-(6-{[(1R)-1-(hydroxymethyl)propyl]amino}imidazo[1,2- b]pyridazin-3-yl)benzoic acid | A | 3BQR | 0.71 | |
HPM | N-{5-[(7-{[(2S)-2-HYDROXY-3-PIPERIDIN- 1-YLPROPYL]OXY}-6-METHOXYQUINAZOLIN- 4-YL)AMINO]PYRIMIDIN-2-YL}BENZAMIDE | A,B | 2C6E | 0.7 | |
G6H | N-{4-methyl-3-[(3-{4-[(3,4,5-trimethoxyphenyl)amino]- 1,3,5-triazin-2-yl}pyridin-2-yl)amino]phenyl}- 3-(trifluoromethyl)benzamide | B | 3G6H | 0.71 | |
TND | N-1,2,3,4-TETRAHYDRONAPHTH-1-YL- 2'-[3,5-DIMETHOXYBENZAMIDO]-2'- DEOXY-ADENOSINE | A,B,C,D,E,F | 1I33 | 0.71 | |
368 | (1R)-2-{[AMINO(IMINO)METHYL]AMINO}- 1-{4-[(4R)-4-(HYDROXYMETHYL)-1,3,2- DIOXABOROLAN-2-YL]PHENYL}ETHYL NICOTINATE | A | 1ZLR | 0.78 | |
S91 | [4-({5-(AMINOCARBONYL)-4-[(3-METHYLPHENYL)AMINO]PYRIMIDIN- 2-YL}AMINO)PHENYL]ACETIC ACID | A | 2Z8C | 0.72 | |
| S91 | [4-({5-(AMINOCARBONYL)-4-[(3-METHYLPHENYL)AMINO]PYRIMIDIN- 2-YL}AMINO)PHENYL]ACETIC ACID | A | 2Z7L | 0.72 | |
CND | 5-BETA-D-RIBOFURANOSYLNICOTINAMIDE ADENINE DINUCLEOTIDE | A,B | 1ADB | 0.73 | |
MOT | N-[4-[(2,4-DIAMINOFURO[2,3D]PYRIMIDIN- 5-YL)METHYL]METHYLAMINO]-BENZOYL]- L-GLUTAMATE | A | 1HFR | 0.71 | |
| MOT | N-[4-[(2,4-DIAMINOFURO[2,3D]PYRIMIDIN- 5-YL)METHYL]METHYLAMINO]-BENZOYL]- L-GLUTAMATE | A | 1DAJ | 0.71 | |
| MOT | N-[4-[(2,4-DIAMINOFURO[2,3D]PYRIMIDIN- 5-YL)METHYL]METHYLAMINO]-BENZOYL]- L-GLUTAMATE | A | 1HFQ | 0.71 | |
| MOT | N-[4-[(2,4-DIAMINOFURO[2,3D]PYRIMIDIN- 5-YL)METHYL]METHYLAMINO]-BENZOYL]- L-GLUTAMATE | A | 1HFP | 0.71 | |
AQZ | N-(3-{[7-METHOXY-6-(2-PYRROLIDIN- 1-YLETHOXY)QUINAZOLIN-4-YL]AMINO}- 4-METHYLPHENYL)-2-MORPHOLIN-4-YLISONICOTINAMIDE | A | 2BAK | 0.71 | |
138 | A,B,C,D | 1JKX | 0.71 | | |
A3D | 3-ACETYLPYRIDINE ADENINE DINUCLEOTIDE | A,B,C,D | 1PZG | 0.7 | |
| A3D | 3-ACETYLPYRIDINE ADENINE DINUCLEOTIDE | A | 1DRV | 0.7 | |
| A3D | 3-ACETYLPYRIDINE ADENINE DINUCLEOTIDE | A,B | 2EWD | 0.7 | |
| A3D | 3-ACETYLPYRIDINE ADENINE DINUCLEOTIDE | A,B,C,D | 1PZF | 0.7 | |
447 | N-(4-{[6-methoxy-7-(3-morpholin- 4-ylpropoxy)quinazolin-4-yl]amino}phenyl)benzamide | A,B | 2VRX | 0.72 | |
PAD | 5-BETA-D-RIBOFURANOSYLPICOLINAMIDE ADENINE- DINUCLEOTIDE | A | 1A72 | 0.71 | |
| PAD | 5-BETA-D-RIBOFURANOSYLPICOLINAMIDE ADENINE- DINUCLEOTIDE | A,B | 1ADC | 0.71 | |
C80 | (2S,4S,5R,7R)-4-AMINO-8-(BUTYLAMINO)- 5-HYDROXY-2,7-DIMETHYL-8-OXOOCTYL 1- BENZYL-1H-INDOLE-3-CARBOXYLATE | C,O | 2V11 | 0.72 | |
DOT | 3'ANTHRANILOYL-2'-DEOXY-ADENOSINE- 5'-TRIPHOSPHATE | A,B,C,D,E,F | 1LVC | 0.79 | |
NXX | A,B,C,D | 3DLA | 0.73 | | |
| NXX | A,B,C | 2QTR | 0.73 | | |
859 | 2-({2-[(3-HYDROXYPHENYL)AMINO]PYRIMIDIN- 4-YL}AMINO)BENZAMIDE | A,B | 2NO3 | 0.73 | |
MS1 | A,B | 1OZ0 | 0.72 | | |
1SM | METHYL 2-[({[(4,6-DIMETHYLPYRIMIDIN- 2-YL)AMINO]CARBONYL}AMINO)SULFONYL]BENZOATE | A,B | 1T9C | 0.7 | |
| 1SM | METHYL 2-[({[(4,6-DIMETHYLPYRIMIDIN- 2-YL)AMINO]CARBONYL}AMINO)SULFONYL]BENZOATE | A | 1YI0 | 0.7 | |
BI9 | 2-({5-CHLORO-2-[(2-METHOXY-4-MORPHOLIN- 4-YLPHENYL)AMINO]PYRIMIDIN-4-YL}AMINO)- N-METHYLBENZAMIDE | A | 2JKK | 0.74 | |
7CS | (3-ENDO)-8-METHYL-8-AZABICYCLO[3.2.1]OCT- 3-YL 1H-PYRROLO[2,3-B]PYRIDINE- 3-CARBOXYLATE | A | 2QHM | 0.75 | |
MNT | 2'(3')-O-N-METHYLANTHRANILOYL-ADENOSINE- 5'-DIPHOSPHATE | A | 1LVK | 0.81 | |
PLB | 2-[(2,4-DICHLOROBENZOYL)AMINO]- 5-(PYRIMIDIN-2-YLOXY)BENZOIC ACID | A,D | 3DZU | 0.71 | |
| PLB | 2-[(2,4-DICHLOROBENZOYL)AMINO]- 5-(PYRIMIDIN-2-YLOXY)BENZOIC ACID | B | 2Q6S | 0.71 | |
| PLB | 2-[(2,4-DICHLOROBENZOYL)AMINO]- 5-(PYRIMIDIN-2-YLOXY)BENZOIC ACID | X | 1WM0 | 0.71 | |
2SM | methyl 2-{[(4-methylpyrimidin-2- yl)carbamoyl]sulfamoyl}benzoate | A | 3EA4 | 0.75 | |
NFL | 2-{[3-(TRIFLUOROMETHYL)PHENYL]AMINO}NICOTINIC ACID | A | 1TD7 | 0.7 | |
CNA | CARBA-NICOTINAMIDE-ADENINE-DINUCLEOTIDE | A,B | 1SZC | 0.71 | |
| CNA | CARBA-NICOTINAMIDE-ADENINE-DINUCLEOTIDE | A | 1A26 | 0.71 | |
| CNA | CARBA-NICOTINAMIDE-ADENINE-DINUCLEOTIDE | A,B | 2OD2 | 0.71 | |
ONM | 3'-O-(N-METHYLANTHRANILOYL)-GUANOSINE- 5'-TRIPHOSPHATE | A,C | 1TL7 | 0.76 | |
| ONM | 3'-O-(N-METHYLANTHRANILOYL)-GUANOSINE- 5'-TRIPHOSPHATE | A,C | 1U0H | 0.76 | |
ZZB | A | 2WFG | 0.7 | | |
PUY | PUROMYCIN | A,B | 2DPT | 0.71 | |
| PUY | PUROMYCIN | 1,2,4,5,A,B, C,D,E,J,K,L, M,N,O,P,R,S, T,U,V,Z | 1Q7Y | 0.71 | |
P40 | N-cyclopropyl-4-methyl-3-{2-[(2- morpholin-4-ylethyl)amino]quinazolin- 6-yl}benzamide | A | 3DT1 | 0.7 | |